Autolus Therapeutics AUTL
NASDAQ AUTL
$1.86 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Autolus Therapeutics (AUTL) Gross Margin (2024 - 2026)

Updated

Autolus Therapeutics' Gross Margin was 55.20% in Q2 2026, up 72.03 percentage points from -16.83% a year earlier.

Analysis

Autolus Therapeutics (AUTL) Gross Margin (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Autolus Therapeutics' Gross Margin was 11.78% through Jun 30, 2026, up 91.46 percentage points year-over-year; for FY2025, it was -27.83%, down 15.31 percentage points from FY2024.

  • In earlier years, Gross Margin was -12.52% in FY2024 (-112.52 pp) and 100.00% in FY2023.
  • The Q2 2026 figure marks the highest quarterly Gross Margin since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Autolus Therapeutics 660.38 Mn -663.71 Mn 25.22 Mn 55.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.20%
Dec 31, 2025 -4.29%
Sep 30, 2025 -35.15%
Jun 30, 2025 -16.83%
Mar 31, 2025 -99.86%
Dec 31, 2024 -39,165.52%
Mar 31, 2024 100.00%
API Access

Autolus Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEY